IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, F5

Definition : Molecular assay reagents intended to identify genetic mutations in the proaccelerin, labile factor (F5) gene, located at chromosome 1q23, which encodes for coagulation factor V. Mutations at this locus have been identified in patients with factor V Leiden thrombophilia.

Entry Terms : "Factor V Leiden Deficiency Gene Mutation Detection Reagents" , "Hemorrhagic Diathesis/Factor V Deficiency Gene Mutation Detection Reagents" , "Factor V Leiden Thrombophilia Gene Mutation Detection Reagents" , "Owren's Disease Diagnostic Reagents" , "Coagulation Factor 5 Gene Mutation Detection Reagents" , "Thrombophilia Gene Mutation Detection Reagents" , "Owren's Disease Associated Diagnostic Reagents" , "Factor V Leiden Disorder Diagnostic Reagents" , "Coagulation Factor V Disorder Diagnostic Reagents" , "IVD Test Reagent/Kits, Molecular Assay, Inborn Disorder, Monogenic, Coagulation Factor V" , "F5 Gene Mutation Detection Reagents" , "Thrombophilia Diagnostic Reagents" , "IVD Test Reagent/Kits, Molecular Assay, Inborn Disorder, Monogenic, Thrombophilia" , "Owren's Disease Determination Reagents" , "Reagents, Molecular Assay, Gene Anomaly, Mutation, F5"

UMDC code : 24410

U.S.companies only
Suppress Subsidiary Companies

1-5 of 5 Match(es).

AutoGenomics Inc

Company Type: Parent

AutoGenomics, Inc., a privately held company based in Vista, CA has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genetic biomarkers in the areas of women's health, cancer and personalized medicine. With discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to a new era of personalized medicine.

GenMark Diagnostics Inc

Company Type: Parent

GenMark Diagnostics is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark's proprietary eSensor detection technology, GenMark's eSensor XT-8 system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges.

Hologic Inc

Company Type: Parent

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world.

Mayo Medical Laboratories

Company Type: Parent

Nanosphere Inc

Company Type: Parent

Nanosphere develops, manufactures and markets an advanced molecular diagnostic platform, the Verigene System, which enables simple, cost-effective, and highly sensitive nucleic acid (DNA and RNA) and protein testing on a single platform.

1-5 of 5 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone